Endothelial Cells Strengthening: Improving Functions in Management of Acute Coronary Syndrome (A Double Blind Randomized Interventional Control Trial)
Journal Title: Clinical Cardiology and Cardiovascular Medicine - Year 2019, Vol 3, Issue 1
Abstract
Objective: Endothelial dysfunction/injury is the main reason for Acute Coronary Syndrome (ACS). Current therapy includes antiplatelet, lipid lowering and thrombus removal by drugs/ intervention. Endothelial strengthening in management of ACS is less narrated in literature. This study describes endothelial strengthening and clinical outcome in ACS with Triphala powder, a mixture of Amla (Phyllanthus emblica), Harad (Terminalia chebula), and Behda (Terminalia bellirica). Methods: This is a double blind randomized interventional control trial. 80 cases coming to the emergency department were selected for study, divided into two groups. Group 1 (n=40, control), group 2 (n=40, study). Further subdivided into subgroup 1A and 2A ST-Elevation Myocardial Infarction (STEMI) and subgroup 1B and 2B Unstable Angina (UA). All subgroups were given clopidogrel, aspirin and atorvastatin and subjected to thrombolysis or Coronary Angiography (CAG) according to requirement. In addition study group was given Triphala powder 10 grams in a cup of water. Outcome was observed for relief in chest pain, ECG, Echocardiography changes at 50 minutes; (SSR) Sympathetic Skin Response was done initially. Statistical analysis was done by SPSS 20 software. Results: In intervention subgroups 2A and 2B there was significant relief in chest pain, settling down of ECG changes, and improvement in regional wall motion in echocardiography (p<0.001). There was increased sympathetic activity in all subgroups (spike response in SSR). Conclusion: Sudden mismatch in ATP (Adenosine Triphosphate) supply results in endothelial dysfunction. It occurs primarily due to increase in sympathetic discharge. Endothelial dysfunction results in UA/STEMI. Triphala increases ATP synthesis by increasing mitochondrial capacity to maximum; strengthens endothelium which behaves like normal endothelium and resolves symptoms and signs of ACS.
Authors and Affiliations
Tarun Saxena
Keywords
Related Articles
- EP ID EP603243
- DOI 10.33805/2639.6807.120
- Views 79
- Downloads 0
Current Evidence for the Use of Aspirin in Patients with Atrial Fibrillation and a CHA2DS2-Vasc=1
Aspirin was once the mainstay of stroke prevention in patients with atrial fibrillation. Its popularity was based on the results of the SPAF and PATAF trials, which showed the low risks of this therapy and the many benef...
Reversible Stress Induced Cardiomyopathy in Adrenal Insufficiency
It’s evident in the literature that Addisonian crisis is tightly linked with cardiovascular manifestations, with very few cases reporting an associated between adrenal insufficiency and reversible cardiomyopathy. We repo...
Electrocardiogram Interpretation: An Exploration of Knowledge and Practice among Secondary Care Hospital's Emergency Physicians
Background: An electrocardiogram (ECG) is a simple, easy, low cost and routine diagnostic tool. Nearly all private secondary hospitals of Pakistan have this facility. It is non-invasive, cardiac evaluation test. It has u...
Six-Minute Walk Test in Pediatric Cardiac Patients
Background: The 6MWT (6MWT) is a self-paced walking test generally used to assess the functional capacity in people with chronic conditions the main outcome is the distance that a person can walk in 6 minutes. The 6 MWT...
Is Expanding Heart Always Serious?
Left Ventricular Pseudo Aneurysm (LVPA) is a rare complication occurs in population that carries the risk. Clinical presentation of a large LVPA can be variable which make the diagnosis challenging. Given the high risk o...